Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy

Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are two of the most fatal respiratory diseases, seriously threatening human health and imposing a heavy burden on families and society. Although COPD is a significant independent risk factor for LC, it is still unclear how COPD affect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Mao, Huang, Zongyao, Chen, Yingfu, Xiao, Hongtao, Wang, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751394/
https://www.ncbi.nlm.nih.gov/pubmed/36532019
http://dx.doi.org/10.3389/fimmu.2022.1038715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751394/
https://www.ncbi.nlm.nih.gov/pubmed/36532019
http://dx.doi.org/10.3389/fimmu.2022.1038715

Ejemplares similares